<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34281203</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>13</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Network Analysis Identifies Sex-Specific Gene Expression Changes in Blood of Amyotrophic Lateral Sclerosis Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7150</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22137150</ELocationID><Abstract><AbstractText>Understanding the molecular mechanisms underlying the pathogenesis of amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease, is a major challenge. We used co-expression networks implemented by the SWitch Miner software to identify switch genes associated with drastic transcriptomic changes in the blood of ALS patients. Functional analyses revealed that switch genes were enriched in pathways related to the cell cycle, hepatitis C, and small cell lung cancer. Analysis of switch genes by sex revealed that switch genes from males were associated with metabolic pathways, including PI3K-AKT, sphingolipid, carbon metabolism, FOXO, and AMPK signaling. In contrast, female switch genes related to infectious diseases, inflammation, apoptosis, and atherosclerosis. Furthermore, eight switch genes showed sex-specific gene expression patterns. Collectively, we identified essential genes and pathways that may explain sex differences observed in ALS. Future studies investigating the potential role of these genes in driving disease disparities between males and females with ALS are warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santiago</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>NeuroHub Analytics, LLC, Chicago, IL 60605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Q Regulating Systems, LLC, Gurnee, IL 60031, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potashkin</LastName><ForeName>Judith A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-8782-3071</Identifier><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and Therapeutics, Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG062176</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG062176</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="Y">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="N">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">blood</Keyword><Keyword MajorTopicYN="N">co-expression networks</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">sex differences</Keyword><Keyword MajorTopicYN="N">switch genes</Keyword></KeywordList><CoiStatement>J.A.S. is the founder of NeuroHub Analytics, LLC. J.P.Q. is the founder of Q Regulating Systems, LLC. J.A.P. declares no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34281203</ArticleId><ArticleId IdType="pmc">PMC8269377</ArticleId><ArticleId IdType="doi">10.3390/ijms22137150</ArticleId><ArticleId IdType="pii">ijms22137150</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grad L.I., Rouleau G.A., Ravits J., Cashman N.R. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS) Cold Spring Harb. Perspect. Med. 2017;7:a024117. doi: 10.1101/cshperspect.a024117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024117</ArticleId><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., Roos P.M., Piehl F., Kamel F., Fang F. Risk factors for amyotrophic lateral sclerosis. Clin. Epidemiol. 2015;7:181&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Strykowski R., Meyer M., Mulcrone P., Krakora D., Suzuki M. Male-specific differences in proliferation, neurogenesis, and sensitivity to oxidative stress in neural progenitor cells derived from a rat model of ALS. PLoS ONE. 2012;7:e48581. doi: 10.1371/journal.pone.0048581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048581</ArticleId><ArticleId IdType="pmc">PMC3493558</ArticleId><ArticleId IdType="pubmed">23144905</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau E., Di Polo A., Vande Velde C., Robitaille R. Sex-Specific Differences in Motor-Unit Remodeling in a Mouse Model of ALS. eNeuro. 2020;7:ENEURO.0388-19.2020. doi: 10.1523/ENEURO.0388-19.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0388-19.2020</ArticleId><ArticleId IdType="pmc">PMC7044502</ArticleId><ArticleId IdType="pubmed">32033983</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Henderson R.D. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7:557&#x2013;570. doi: 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P., Corcia P., Lautrette G., Nicol M., Preux P.M., Marin B. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Rev. Neurol. 2016;172:37&#x2013;45. doi: 10.1016/j.neurol.2015.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2015.11.002</ArticleId><ArticleId IdType="pubmed">26727307</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M., Wuu J., Andersen P.M., Lombardi V., Malaspina A. Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion. Ann. Neurol. 2018;84:130&#x2013;139. doi: 10.1002/ana.25276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25276</ArticleId><ArticleId IdType="pubmed">30014505</ArticleId></ArticleIdList></Reference><Reference><Citation>Preische O., Schultz S.A., Apel A., Kuhle J., Kaeser S.A., Barro C., Graber S., Kuder-Buletta E., LaFougere C., Laske C., et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer&#x2019;s disease. Nat. Med. 2019;25:277&#x2013;283. doi: 10.1038/s41591-018-0304-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0304-3</ArticleId><ArticleId IdType="pmc">PMC6367005</ArticleId><ArticleId IdType="pubmed">30664784</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K.B., Glass J.D., Crook J.E., Yang C., Thomas C.S., Desaro P., Johnston A., Overstreet K., Kelly C., Polak M., et al. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2013;84:467&#x2013;472. doi: 10.1136/jnnp-2012-303768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303768</ArticleId><ArticleId IdType="pubmed">23117489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrhart J., Smith A.J., Kuzmin-Nichols N., Zesiewicz T.A., Jahan I., Shytle R.D., Kim S.H., Sanberg C.D., Vu T.H., Gooch C.L., et al. Humoral factors in ALS patients during disease progression. J. Neuroinflammation. 2015;12:127. doi: 10.1186/s12974-015-0350-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0350-4</ArticleId><ArticleId IdType="pmc">PMC4487852</ArticleId><ArticleId IdType="pubmed">26126965</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago J.A., Potashkin J.A. A network approach to clinical intervention in neurodegenerative diseases. Trends Mol. Med. 2014;20:694&#x2013;703. doi: 10.1016/j.molmed.2014.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2014.10.002</ArticleId><ArticleId IdType="pubmed">25455073</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago J.A., Bottero V., Potashkin J.A. Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology. Front. Aging Neurosci. 2017;9:166. doi: 10.3389/fnagi.2017.00166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00166</ArticleId><ArticleId IdType="pmc">PMC5446999</ArticleId><ArticleId IdType="pubmed">28611656</ArticleId></ArticleIdList></Reference><Reference><Citation>Potashkin J.A., Bottero V., Santiago J.A., Quinn J.P. Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer&#x2019;s patients. PLoS ONE. 2019;14:e0222921. doi: 10.1371/journal.pone.0222921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0222921</ArticleId><ArticleId IdType="pmc">PMC6756555</ArticleId><ArticleId IdType="pubmed">31545826</ArticleId></ArticleIdList></Reference><Reference><Citation>Potashkin J.A., Bottero V., Santiago J.A., Quinn J.P. Bioinformatic Analysis Reveals Phosphodiesterase 4D-Interacting Protein as a Key Frontal Cortex Dementia Switch Gene. Int. J. Mol. Sci. 2020;21:3787. doi: 10.3390/ijms21113787.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21113787</ArticleId><ArticleId IdType="pmc">PMC7313474</ArticleId><ArticleId IdType="pubmed">32471155</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiscon G., Conte F., Licursi V., Nasi S., Paci P. Computational identification of specific genes for glioblastoma stem-like cells identity. Sci. Rep. 2018;8:7769. doi: 10.1038/s41598-018-26081-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-26081-5</ArticleId><ArticleId IdType="pmc">PMC5958093</ArticleId><ArticleId IdType="pubmed">29773872</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Zhou G., Soufan O., Xia J. miRNet 2.0: Network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48:W244&#x2013;W251. doi: 10.1093/nar/gkaa467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa467</ArticleId><ArticleId IdType="pmc">PMC7319552</ArticleId><ArticleId IdType="pubmed">32484539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G., Soufan O., Ewald J., Hancock R.E.W., Basu N., Xia J. NetworkAnalyst 3.0: A visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47:W234&#x2013;W241. doi: 10.1093/nar/gkz240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz240</ArticleId><ArticleId IdType="pmc">PMC6602507</ArticleId><ArticleId IdType="pubmed">30931480</ArticleId></ArticleIdList></Reference><Reference><Citation>Plath K., Mlynarczyk-Evans S., Nusinow D.A., Panning B. Xist RNA and the mechanism of X chromosome inactivation. Annu. Rev. Genet. 2002;36:233&#x2013;278. doi: 10.1146/annurev.genet.36.042902.092433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.genet.36.042902.092433</ArticleId><ArticleId IdType="pubmed">12429693</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunford A., Weinstock D.M., Savova V., Schumacher S.E., Cleary J.P., Yoda A., Sullivan T.J., Hess J.M., Gimelbrant A.A., Beroukhim R., et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat. Genet. 2017;49:10&#x2013;16. doi: 10.1038/ng.3726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3726</ArticleId><ArticleId IdType="pmc">PMC5206905</ArticleId><ArticleId IdType="pubmed">27869828</ArticleId></ArticleIdList></Reference><Reference><Citation>Berletch J.B., Deng X., Nguyen D.K., Disteche C.M. Female bias in Rhox6 and 9 regulation by the histone demethylase KDM6A. PLoS Genet. 2013;9:e1003489. doi: 10.1371/journal.pgen.1003489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003489</ArticleId><ArticleId IdType="pmc">PMC3642083</ArticleId><ArticleId IdType="pubmed">23658530</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh Y., Golden L.C., Itoh N., Matsukawa M.A., Ren E., Tse V., Arnold A.P., Voskuhl R.R. The X-linked histone demethylase Kdm6a in CD4+ T lymphocytes modulates autoimmunity. J. Clin. Investig. 2019;129:3852&#x2013;3863. doi: 10.1172/JCI126250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI126250</ArticleId><ArticleId IdType="pmc">PMC6715385</ArticleId><ArticleId IdType="pubmed">31403472</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S.J. Destabilizing influences in apoptosis: Sowing the seeds of IAP destruction. Cell. 2002;109:793&#x2013;796. doi: 10.1016/S0092-8674(02)00802-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00802-4</ArticleId><ArticleId IdType="pubmed">12110175</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrelet D., Perrin F.E., Liston P., Korneluk R.G., MacKenzie A., Ferrer-Alcon M., Kato A.C. Motoneuron resistance to apoptotic cell death in vivo correlates with the ratio between X-linked inhibitor of apoptosis proteins (XIAPs) and its inhibitor, XIAP-associated factor 1. J. Neurosci. 2004;24:3777&#x2013;3785. doi: 10.1523/JNEUROSCI.0413-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0413-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729352</ArticleId><ArticleId IdType="pubmed">15084658</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X., Cao Y., Stucchi R., Hooikaas P.J., Portegies S., Will L., Martin M., Akhmanova A., Harterink M., Hoogenraad C.C. MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon. Cell Rep. 2019;26:1988&#x2013;1999.e6. doi: 10.1016/j.celrep.2019.01.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.01.084</ArticleId><ArticleId IdType="pmc">PMC6381606</ArticleId><ArticleId IdType="pubmed">30784582</ArticleId></ArticleIdList></Reference><Reference><Citation>Young-Baird S.K., Lourenco M.B., Elder M.K., Klann E., Liebau S., Dever T.E. Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB. Mol. Cell. 2020;77:875&#x2013;886.e7. doi: 10.1016/j.molcel.2019.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.11.008</ArticleId><ArticleId IdType="pmc">PMC7035991</ArticleId><ArticleId IdType="pubmed">31836389</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanda K., Mukhopadhyay D. LncRNA Xist, X-chromosome Instability and Alzheimer&#x2019;s Disease. Curr. Alzheimer Res. 2020;17:499&#x2013;507. doi: 10.2174/1567205017666200807185624.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205017666200807185624</ArticleId><ArticleId IdType="pubmed">32851944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Wang C., Geng C., Zhao K. LncRNA XIST knockdown attenuates Abeta25-35-induced toxicity, oxidative stress, and apoptosis in primary cultured rat hippocampal neurons by targeting miR-132. Int. J. Clin. Exp. Pathol. 2018;11:3915&#x2013;3924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6962802</ArticleId><ArticleId IdType="pubmed">31949779</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Gao G., Li J., Suo S., Liu S., Sun Y., Zhang M., Yin P., Lu C., Zhang Z., et al. Silencing of long noncoding RNA XIST attenuated Alzheimer&#x2019;s disease-related BACE1 alteration through miR-124. Cell Biol. Int. 2020;44:630&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">31743528</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield A., Carrel L., Pennisi D., Philippe C., Quaderi N., Siggers P., Steiner K., Tam P.P., Monaco A.P., Willard H.F., et al. The UTX gene escapes X inactivation in mice and humans. Hum. Mol. Genet. 1998;7:737&#x2013;742. doi: 10.1093/hmg/7.4.737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/7.4.737</ArticleId><ArticleId IdType="pubmed">9499428</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis E.J., Broestl L., Abdulai-Saiku S., Worden K., Bonham L.W., Minones-Moyano E., Moreno A.J., Wang D., Chang K., Williams G., et al. A second X chromosome contributes to resilience in a mouse model of Alzheimer&#x2019;s disease. Sci. Transl. Med. 2020;12:eaaz5677. doi: 10.1126/scitranslmed.aaz5677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaz5677</ArticleId><ArticleId IdType="pubmed">32848093</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Zhang Q., Shi Q., Liu Y., Zhao K., Shen Q., Shi Y., Liu X., Wang C., Li N., et al. Demethylase Kdm6a epigenetically promotes IL-6 and IFN-beta production in macrophages. J. Autoimmun. 2017;80:85&#x2013;94. doi: 10.1016/j.jaut.2017.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2017.02.007</ArticleId><ArticleId IdType="pubmed">28284523</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider-Gadicke A., Beer-Romero P., Brown L.G., Nussbaum R., Page D.C. ZFX has a gene structure similar to ZFY, the putative human sex determinant, and escapes X inactivation. Cell. 1989;57:1247&#x2013;1258. doi: 10.1016/0092-8674(89)90061-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90061-5</ArticleId><ArticleId IdType="pubmed">2500252</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Duan P., Li J., Senkowski T., Guo F., Chen H., Romero A., Cui Y., Liu J., Jiang S.W. Zinc Finger and X-Linked Factor (ZFX) Binds to Human SET Transcript 2 Promoter and Transactivates SET Expression. Int. J. Mol. Sci. 2016;17:1737. doi: 10.3390/ijms17101737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17101737</ArticleId><ArticleId IdType="pmc">PMC5085766</ArticleId><ArticleId IdType="pubmed">27775603</ArticleId></ArticleIdList></Reference><Reference><Citation>Arif M., Wei J., Zhang Q., Liu F., Basurto-Islas G., Grundke-Iqbal I., Iqbal K. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau. J. Biol. Chem. 2014;289:27677&#x2013;27691. doi: 10.1074/jbc.M114.565358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.565358</ArticleId><ArticleId IdType="pmc">PMC4183805</ArticleId><ArticleId IdType="pubmed">25128526</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly Z.R., Scott K.M., Abhinav K., Wijesekera L., Ganesalingam J., Goldstein L.H., Janssen A., Dougherty A., Willey E., Stanton B.R., et al. The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph. Lateral Scler. 2010;11:439&#x2013;442. doi: 10.3109/17482961003610853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003610853</ArticleId><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis A.F., Masellis M., Hsiung G.R., Moineddin R., Zhang K., Au B., Millett G., Mackenzie I., Rogaeva E., Tierney M.C. Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis. Neurology. 2017;89:1633&#x2013;1642. doi: 10.1212/WNL.0000000000004494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004494</ArticleId><ArticleId IdType="pmc">PMC5634668</ArticleId><ArticleId IdType="pubmed">28916533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershoni M., Pietrokovski S. The landscape of sex-differential transcriptome and its consequent selection in human adults. BMC Biol. 2017;15:7. doi: 10.1186/s12915-017-0352-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-017-0352-z</ArticleId><ArticleId IdType="pmc">PMC5297171</ArticleId><ArticleId IdType="pubmed">28173793</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuda H., Han S.M., Yang Y., Tong C., Lin Y.Q., Mohan K., Haueter C., Zoghbi A., Harati Y., Kwan J., et al. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell. 2008;133:963&#x2013;977. doi: 10.1016/j.cell.2008.04.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.04.039</ArticleId><ArticleId IdType="pmc">PMC2494862</ArticleId><ArticleId IdType="pubmed">18555774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta G., Qin H., Song J. Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a &#x201c;fuzzy complex&#x201d; with VAPB-MSP domain which carries ALS-causing mutations. PLoS ONE. 2012;7:e39261. doi: 10.1371/journal.pone.0039261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039261</ArticleId><ArticleId IdType="pmc">PMC3374797</ArticleId><ArticleId IdType="pubmed">22720086</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhvlediani T., Kvirkvelia N., Shakarishvili R., Tsertsvadze T. Als-like syndrome in the patient with chronic hepatitis C. Georgian Med. News. 2009;172&#x2013;173:70&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">19644195</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannahill D., Melton D.A. Localized synthesis of the Vg1 protein during early Xenopus development. Development. 1989;106:775&#x2013;785. doi: 10.1242/dev.106.4.775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.106.4.775</ArticleId><ArticleId IdType="pubmed">2562668</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko N.F., McMillan P.J., Guthrie C.R., Bird T.D., Leverenz J.B., Kraemer B.C. CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration. Ann. Neurol. 2013;74:39&#x2013;52. doi: 10.1002/ana.23870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23870</ArticleId><ArticleId IdType="pmc">PMC3775949</ArticleId><ArticleId IdType="pubmed">23424178</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Prats E., Martinez-Gonzalez L., Gonzalo-Consuegra C., Liachko N.F., Perez C., Ramirez D., Kraemer B.C., Martin-Requero A., Perez D.I., Gil C., et al. Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis. Eur. J. Med. Chem. 2021;210:112968. doi: 10.1016/j.ejmech.2020.112968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112968</ArticleId><ArticleId IdType="pubmed">33139113</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaca G., Martinez-Gonzalez L., Fernandez A., Rojas-Prats E., Porras G., Cuevas E.P., Gil C., Martinez A., Martin-Requero A. Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) J. Neurochem. 2021;156:379&#x2013;390. doi: 10.1111/jnc.15118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15118</ArticleId><ArticleId IdType="pubmed">32628315</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenherr C.J., Anderson D.J. The neuron-restrictive silencer factor (NRSF): A coordinate repressor of multiple neuron-specific genes. Science. 1995;267:1360&#x2013;1363. doi: 10.1126/science.7871435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7871435</ArticleId><ArticleId IdType="pubmed">7871435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu T., Aron L., Zullo J., Pan Y., Kim H., Chen Y., Yang T.H., Kim H.M., Drake D., Liu X.S., et al. REST and stress resistance in ageing and Alzheimer&#x2019;s disease. Nature. 2014;507:448&#x2013;454. doi: 10.1038/nature13163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13163</ArticleId><ArticleId IdType="pmc">PMC4110979</ArticleId><ArticleId IdType="pubmed">24670762</ArticleId></ArticleIdList></Reference><Reference><Citation>Formisano L., Guida N., Cocco S., Secondo A., Sirabella R., Ulianich L., Paturzo F., Di Renzo G., Canzoniero L.M. The repressor element 1-silencing transcription factor is a novel molecular target for the neurotoxic effect of the polychlorinated biphenyl mixture aroclor 1254 in neuroblastoma SH-SY5Y cells. J. Pharmacol. Exp. Ther. 2011;338:997&#x2013;1003. doi: 10.1124/jpet.111.181289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.111.181289</ArticleId><ArticleId IdType="pubmed">21693630</ArticleId></ArticleIdList></Reference><Reference><Citation>Recabarren-Leiva D., Alarcon M. New insights into the gene expression associated to amyotrophic lateral sclerosis. Life Sci. 2018;193:110&#x2013;123. doi: 10.1016/j.lfs.2017.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2017.12.016</ArticleId><ArticleId IdType="pubmed">29241710</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Ren M., Jiang H., Cui S., Wang S., Jiang H., Qi Y., Wang J., Wang X., Dong G., et al. Downregulated AEG-1 together with inhibited PI3K/Akt pathway is associated with reduced viability of motor neurons in an ALS model. Mol. Cell. Neurosci. 2015;68:303&#x2013;313. doi: 10.1016/j.mcn.2015.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.08.009</ArticleId><ArticleId IdType="pubmed">26320681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranno E., D&#x2019;Antoni S., Spatuzza M., Berretta A., Laureanti F., Bonaccorso C.M., Pellitteri R., Longone P., Spalloni A., Iyer A.M., et al. Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death. Neurobiol. Dis. 2014;65:160&#x2013;171. doi: 10.1016/j.nbd.2014.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.01.002</ArticleId><ArticleId IdType="pubmed">24423643</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Antoni S., Ranno E., Spatuzza M., Cavallaro S., Catania M.V. Endothelin-1 Induces Degeneration of Cultured Motor Neurons Through a Mechanism Mediated by Nitric Oxide and PI3K/Akt Pathway. Neurotox. Res. 2017;32:58&#x2013;70. doi: 10.1007/s12640-017-9711-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-017-9711-3</ArticleId><ArticleId IdType="pubmed">28285347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A., Munger K.L., Lunemann J.D. The initiation and prevention of multiple sclerosis. Nat. Rev. Neurol. 2012;8:602&#x2013;612. doi: 10.1038/nrneurol.2012.198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.198</ArticleId><ArticleId IdType="pmc">PMC4467212</ArticleId><ArticleId IdType="pubmed">23045241</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardie D.G., Ross F.A., Hawley S.A. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012;13:251&#x2013;262. doi: 10.1038/nrm3311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3311</ArticleId><ArticleId IdType="pmc">PMC5726489</ArticleId><ArticleId IdType="pubmed">22436748</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago J.A., Bottero V., Potashkin J.A. Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer&#x2019;s Disease. Front. Neurosci. 2019;13:1273. doi: 10.3389/fnins.2019.01273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01273</ArticleId><ArticleId IdType="pmc">PMC6895844</ArticleId><ArticleId IdType="pubmed">31849586</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui A., Fan H., Zhang Y., Zhang Y., Niu D., Liu S., Liu Q., Ma W., Shen Z., Shen L., et al. Dexamethasone-induced Kruppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia. J. Clin. Investig. 2019;129:2266&#x2013;2278. doi: 10.1172/JCI66062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI66062</ArticleId><ArticleId IdType="pmc">PMC6546458</ArticleId><ArticleId IdType="pubmed">31033478</ArticleId></ArticleIdList></Reference><Reference><Citation>Gans I., Hartig E.I., Zhu S., Tilden A.R., Hutchins L.N., Maki N.J., Graber J.H., Coffman J.A. Klf9 is a key feedforward regulator of the transcriptomic response to glucocorticoid receptor activity. Sci. Rep. 2020;10:11415. doi: 10.1038/s41598-020-68040-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68040-z</ArticleId><ArticleId IdType="pmc">PMC7351738</ArticleId><ArticleId IdType="pubmed">32651405</ArticleId></ArticleIdList></Reference><Reference><Citation>Apara A., Galvao J., Wang Y., Blackmore M., Trillo A., Iwao K., Brown D.P., Jr., Fernandes K.A., Huang A., Nguyen T., et al. KLF9 and JNK3 Interact to Suppress Axon Regeneration in the Adult CNS. J. Neurosci. 2017;37:9632&#x2013;9644. doi: 10.1523/JNEUROSCI.0643-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0643-16.2017</ArticleId><ArticleId IdType="pmc">PMC5628408</ArticleId><ArticleId IdType="pubmed">28871032</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Zeng W., Sun H., Huang F., Yang C., Cai X., Lu Y., Zeng J., Yang K. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis. World Neurosurg. 2020;138:e492&#x2013;e514. doi: 10.1016/j.wneu.2020.02.159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2020.02.159</ArticleId><ArticleId IdType="pubmed">32147549</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziuba N., Ferguson M.R., O&#x2019;Brien W.A., Sanchez A., Prussia A.J., McDonald N.J., Friedrich B.M., Li G., Shaw M.W., Sheng J., et al. Identification of cellular proteins required for replication of human immunodeficiency virus type 1. AIDS Res. Hum. Retrovir. 2012;28:1329&#x2013;1339. doi: 10.1089/aid.2011.0358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.2011.0358</ArticleId><ArticleId IdType="pmc">PMC3448097</ArticleId><ArticleId IdType="pubmed">22404213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuschal C., Botta E., Orioli D., Digiovanna J.J., Seneca S., Keymolen K., Tamura D., Heller E., Khan S.G., Caligiuri G., et al. GTF2E2 Mutations Destabilize the General Transcription Factor Complex TFIIE in Individuals with DNA Repair-Proficient Trichothiodystrophy. Am. J. Hum. Genet. 2016;98:627&#x2013;642. doi: 10.1016/j.ajhg.2016.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.02.008</ArticleId><ArticleId IdType="pmc">PMC4833217</ArticleId><ArticleId IdType="pubmed">26996949</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Zhou J., Liao X., Lu Y., Deng C., Huang P., Chen Q., Yang X. Disruption of Smad5 gene induces mitochondria-dependent apoptosis in cardiomyocytes. Exp. Cell Res. 2005;306:85&#x2013;93. doi: 10.1016/j.yexcr.2005.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2005.02.012</ArticleId><ArticleId IdType="pubmed">15878335</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie M., Yu S., Peng S., Fang Y., Wang H., Yang X. miR-23a and miR-27a promote human granulosa cell apoptosis by targeting SMAD5. Biol. Reprod. 2015;93:98. doi: 10.1095/biolreprod.115.130690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1095/biolreprod.115.130690</ArticleId><ArticleId IdType="pubmed">26400397</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.L., Behringer R.R., Kwan K.M. Smad1/Smad5 signaling in limb ectoderm functions redundantly and is required for interdigital programmed cell death. Dev. Biol. 2012;363:247&#x2013;257. doi: 10.1016/j.ydbio.2011.12.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2011.12.037</ArticleId><ArticleId IdType="pmc">PMC5134426</ArticleId><ArticleId IdType="pubmed">22240098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegarty S.V., O&#x2019;Keeffe G.W., Sullivan A.M. BMP-Smad 1/5/8 signalling in the development of the nervous system. Prog. Neurobiol. 2013;109:28&#x2013;41. doi: 10.1016/j.pneurobio.2013.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2013.07.002</ArticleId><ArticleId IdType="pubmed">23891815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 2009;1:a001651. doi: 10.1101/cshperspect.a001651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a001651</ArticleId><ArticleId IdType="pmc">PMC2882124</ArticleId><ArticleId IdType="pubmed">20457564</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Lee C., Kodama L., Gan L. Sex Differences in Neurodegeneration: The Role of the Immune System in Humans. Biol. Psychiatry. 2021 doi: 10.1016/j.biopsych.2021.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2021.01.002</ArticleId><ArticleId IdType="pmc">PMC8263798</ArticleId><ArticleId IdType="pubmed">33715827</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., O&#x2019;Rourke J.G., Yanez A., Markman J.L., Ho R., Wang X., Chen S., Lall D., Jin M., Muhammad A., et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature. 2020;585:96&#x2013;101. doi: 10.1038/s41586-020-2625-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N., Kakita A., Takahashi H., Ihara Y., Nobukuni K., Fujimura H., Sakoda S., Sasaki S., Iwata M., Morikawa S., et al. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients. Neurodegener. Dis. 2009;6:118&#x2013;126. doi: 10.1159/000213762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000213762</ArticleId><ArticleId IdType="pubmed">19372705</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal-Oz S.T., Maier B., Yoshida H., Seddu K., Elbaz N., Czysz C., Zuk O., Stranger B.E., Ner-Gaon H., Shay T. ImmGen report: Sexual dimorphism in the immune system transcriptome. Nat. Commun. 2019;10:4295. doi: 10.1038/s41467-019-12348-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12348-6</ArticleId><ArticleId IdType="pmc">PMC6754408</ArticleId><ArticleId IdType="pubmed">31541153</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Z., Zheng M., Zhao L., Xie P., Song C., Chu Y., Song W., He G. Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer&#x2019;s disease mice model. Curr. Alzheimer Res. 2013;10:261&#x2013;269. doi: 10.2174/1567205011310030005.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205011310030005</ArticleId><ArticleId IdType="pubmed">23036022</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Z., Zeng Q., Wang K., Sharma A., He G. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer&#x2019;s disease. Acta Biochim. Biophys. Sin. 2016;48:930&#x2013;938. doi: 10.1093/abbs/gmw085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmw085</ArticleId><ArticleId IdType="pubmed">27614317</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams R.S., Bate C. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling. Neuropharmacology. 2016;101:566&#x2013;575. doi: 10.1016/j.neuropharm.2015.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.06.013</ArticleId><ArticleId IdType="pubmed">26116815</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.Z., Liu Y.J., Zhang W., Luo S.F., Zhou X., He G.Q. Combined treatment with valproic acid and estrogen has neuroprotective effects in ovariectomized mice with Alzheimer&#x2019;s disease. Neural. Regen. Res. 2021;16:2078&#x2013;2085.</Citation><ArticleIdList><ArticleId IdType="pubmed">33642397</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S., Dixit A., Singh A., Tripathi P., Singh D., Patel D.K., Singh M.P. Cyclosporine A and MnTMPyP Alleviate alpha-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism. Mol. Neurobiol. 2015;52:1619&#x2013;1628. doi: 10.1007/s12035-014-8954-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8954-8</ArticleId><ArticleId IdType="pubmed">25370934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulbe J.R., Hill R.L., Singh I.N., Wang J.A., Hall E.D. Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A. J. Neurotrauma. 2017;34:1291&#x2013;1301. doi: 10.1089/neu.2016.4628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2016.4628</ArticleId><ArticleId IdType="pmc">PMC5385586</ArticleId><ArticleId IdType="pubmed">27596283</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Siddiqui S., Gabriely G., Lanser A.J., Dake B., Murugaiyan G., Doykan C.E., Wu P.M., Gali R.R., Iyer L.K., et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Investig. 2012;122:3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincecum J.M., Vieira F.G., Wang M.Z., Thompson K., De Zutter G.S., Kidd J., Moreno A., Sanchez R., Carrion I.J., Levine B.A., et al. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat. Genet. 2010;42:392&#x2013;399. doi: 10.1038/ng.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.557</ArticleId><ArticleId IdType="pubmed">20348957</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>